- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Results
4
Stocks with a market cap under US$50M.
4 companies
Tianda Pharmaceuticals
Market Cap: HK$258.0m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.12
7D
-0.8%
1Y
-36.8%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$220.0m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$1.52
7D
-12.1%
1Y
90.0%
PuraPharm
Market Cap: HK$181.9m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.34
7D
-12.8%
1Y
-48.5%
China Health Group
Market Cap: HK$153.3m
An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.15
7D
-1.3%
1Y
-14.0%